APVO
APVO
NASDAQ · Biotechnology

Aptevo Therapeutics Inc

$0.62
-0.04 (-5.77%)
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Buy 6 86%
Hold 1 14%
Sell 0 0%
Price Target
Analyst Price Target +4,441.8% upside
Low Target $22.50
Average Target $28.25
High Target $48.31
Current Price $0.62
Current
$0.62
Target
$28.25
$22.50 $28.25 avg $48.31
Scenario Analysis
Bear Case
$22.50
3,517.4%
Low target
Base Case
$28.25
+4,441.8%
Avg target
Bull Case
$48.31
+7,666.9%
High target
Risk/Reward
2.2x
Favorable
Price in Context
52-Week High
$28.08
-97.8% from high
52-Week Low
$1.07
+-41.9% from low
Target vs 52W High
$28.25
+0.6% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 38 82% $257.58 -12.5%
AMGN
Amgen Inc
Hold 42 43% $190.87 -59.0%
GILD
Gilead Sciences Inc
Strong Buy 36 83% $362.68 +115.9%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 82% $438.34 -19.2%
MRNA
Moderna Inc
Hold 31 32% $149.45 -35.4%
REGN
Regeneron Pharmaceuticals
Buy 36 72% $76.80 -91.9%
NTRA
Natera Inc
Strong Buy 31 90% $142.91 -55.7%
RVMD
Revolution Medicines Inc
Strong Buy 31 94% $114.11 -35.3%